What are the next steps in treating trochanteric (greater trochanteric) bursitis when initial treatments fail?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Trochanteric Bursitis After Initial Treatment Failure

When first-line treatment with NSAIDs, physical therapy, and activity modification fails, proceed with ultrasound-guided corticosteroid injection into the trochanteric bursa, followed by extracorporeal shock wave therapy if injections are unsuccessful, and reserve surgery only after 3-6 months of comprehensive conservative treatment failure. 1

Second-Line Treatment: Corticosteroid Injections

Injection Protocol

  • Ultrasound-guided corticosteroid injection into the trochanteric bursa is the next step after failed conservative measures, providing both diagnostic confirmation and therapeutic benefit 1
  • Ultrasound guidance significantly improves injection accuracy compared to landmark-based techniques 1
  • Peritrochanteric infiltration with glucocorticoids mixed with 2% lidocaine provides long-term symptom relief, though recurrence should be expected and treatment may be repeated 2

Expected Outcomes

  • Approximately 80% of patients respond to corticosteroid injections, though 45% may require multiple injections 3
  • Symptom resolution rates range from 49% to 100% when corticosteroid injection is used as the primary treatment modality 4
  • Injections should be peritendinous rather than intratendinous, as direct tendon substance injections may have deleterious effects 1

Predictors of Injection Failure

  • Younger patients show a trend toward poorer response to nonoperative management 3
  • Greater limb-length discrepancy is associated with higher failure rates of conservative treatment 3

Third-Line Treatment: Extracorporeal Shock Wave Therapy

If corticosteroid injections fail or provide only temporary relief, extracorporeal shock wave therapy (ESWT) is the preferred next step before considering surgery. 1

  • ESWT is a safe, noninvasive, and effective treatment for chronic tendinopathies that provides pain relief 1
  • Level II and III evidence demonstrates ESWT is superior to other nonoperative modalities including corticosteroid injections 4
  • This modality is particularly appropriate for hip abductor tendinopathy, which frequently coexists with trochanteric bursitis 1

Advanced Physical Therapy

Structured Exercise Program

  • Supervised exercise programs focusing on eccentric strengthening of hip abductor muscles are more effective than passive interventions 1
  • Land-based physical therapy is preferred over aquatic therapy interventions 1
  • Continue relative rest while allowing activities that don't worsen pain 1

Adjunctive Measures

  • Orthotics and bracing can reduce tension on the affected tendon during healing 1
  • Passive interventions (massage, ultrasound, heat) may supplement but should not substitute active physical therapy 1

Surgical Intervention

Surgery should only be considered after failure of 3-6 months of comprehensive conservative treatment. 1

Surgical Options

Multiple surgical techniques have been reported with variable efficacy:

  • Bursectomy 4
  • Longitudinal release of the iliotibial band 4
  • Proximal or distal Z-plasty of the iliotibial band 4
  • Surgical repair of torn abductor tendons when MRI and clinical findings confirm tendon disruption and weakness 1

Surgical Outcomes

  • All surgical techniques demonstrate superiority to corticosteroid therapy and physical therapy according to visual analog scale (VAS) and Harris Hip Scores (HHS) 4
  • Surgery is effective in refractory cases, with outcomes varying by specific technique and clinical outcome measure 4

Critical Diagnostic Considerations

Differentiate Coexisting Conditions

  • Trochanteric bursitis and gluteus medius/minimus tendinosis are difficult to distinguish and frequently coexist 1, 5
  • Most cases actually result from pathology of the gluteus medius or minimus muscles rather than true bursitis 5
  • If not already performed, obtain MRI to comprehensively assess peritrochanteric structures including gluteus minimus and medius muscles, abductor tendons, and the trochanteric bursa 1

Special Populations

  • In patients with hip prostheses, extracapsular disease associated with adverse reactions to metal debris (ARMD) can be misinterpreted as trochanteric bursitis 1
  • Consider systemic rheumatic disease if multiple symptomatic bursae are present 6

Treatment Algorithm Summary

  1. Repeat or optimize conservative measures: Ensure adequate trial of NSAIDs, structured physical therapy with eccentric strengthening, activity modification, and ice application 1

  2. Ultrasound-guided corticosteroid injection: First interventional step, may require multiple injections 1, 3

  3. Extracorporeal shock wave therapy: If injections fail or provide only temporary relief 1, 4

  4. Advanced imaging: Obtain MRI if not already done to assess for gluteal tendon tears or other structural pathology 1

  5. Surgical consultation: Only after documented failure of 3-6 months of comprehensive conservative treatment 1

References

Guideline

Treatment of Trochanteric Bursitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Efficacy of treatment of trochanteric bursitis: a systematic review.

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine, 2011

Research

Evidence-based soft tissue rheumatology: III: trochanteric bursitis.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2004

Guideline

Management of Bursitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.